3-Nonenoic acid, methyl ester
Common Name: |
3-Nonenoic acid, methyl ester |
IUPAC Name: |
methyl (E)-non-3-enoate |
Molecular Formula: |
C10H18O2 |
SMILES: |
CCCCCC=CCC(=O)OC |
Inchi: |
1S/C10H18O2/c1-3-4-5-6-7-8-9-10(11)12-2/h7-8H,3-6,9H2,1-2H3/b8-7+ |
Inchi Key: |
MTDCXFZGUVZRSQ-BQYQJAHWSA-N |
Cas No: |
36781-67-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
170.25 |
Mass (g/mol) |
170.131 |
Molar Refractivity |
50.99 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
7 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
212.66 |
Vapor Pressure (mmHg@25.00 °C) |
0.171 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.70 |
LogP |
2.686 |
iLOGP |
2.98 |
XLOGP3 |
3.15 |
WLOGP |
2.69 |
MLOGP |
2.47 |
ESOL Log S |
-2.42 |
ESOL Solubility (mg/ml) |
0.65 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.37 |
Ali Solubility (mg/ml) |
0.07 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.45 |
Silicos-IT Solubility (mg/ml) |
0.6 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.10 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.713 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.042 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |